© 2025 CellCarta - All rights reserved.
The rigor and quality of your early-stage programs play a defining role in the success of your therapeutic development. Our Lake Forest laboratory offers the histopathology services needed to make rapid, confident decisions — while ensuring the transition to global later-stage programs is seamless.
Pathologist-validated data delivered on early-stage timelines, with the rigor required to support critical program decisions.
As study requirements evolve, we adapt protocols, scope, and timelines to match your scientific direction. Whether your program expands, pivots, or accelerates, we are built to flex with it.
Scientific rigor and quality control processes are at the center of every project — delivering high-quality, reliable results from day one.
Work as one team with our scientists and pathologists — with real-time updates and meaningful dialogue.
Immediate specimen availability eliminates sourcing delays and accelerates project initiation.
Start locally and transition seamlessly across CellCarta's owned global laboratory network as your program advances.
Pathologist-validated data delivered on early-stage timelines, with the rigor required to support critical program decisions.
As study requirements evolve, we adapt protocols, scope, and timelines to match your scientific direction. Whether your program expands, pivots, or accelerates, we are built to flex with it.
The rigor and quality of your early-stage programs play a defining role in the success of your therapeutic development. Our Lake Forest laboratory offers the histopathology services needed to make rapid, confident decisions — while ensuring the transition to later-stage global programs is seamless.
Work as one team with our scientists and pathologists — with real-time updates and meaningful dialogue.
Immediate specimen availability eliminates sourcing delays and accelerates project initiation .
Scientific rigor and quality control processes are at the center of every project — delivering high-quality, reliable results from day one.
Start locally and transition seamlessly across CellCarta’s owned global laboratory network as your program advances.
Trusted by the 17 of the top 20 pharma companies
20 years supporting Phase 1, Phase 2 and Phase 3 programs
From concept to validated histopathology assay in under 3 months.
Platform Agnostic: Dako, Leica, Ventana, Sakura and now the COMET from Lunaphore.
Specialized in ADC biomarker profiling
Trusted by the 17 of the top 20 pharma companies
20 years. Supporting Phase 1, Phase 2, and Phase 3 programs.
From concept to validated histopathology assay in under 3 months.
Platform Agnostic: Dako, Leica, Ventana, Sakura and now the COMET from Lunaphore.
Specialized in ADC biomarker profiling